Cellaxia

Developer of cell therapies focused on intractable and rare diseases

placeTokyo, Tokyo, Japan calendar_todayFounded 2017 language cellaxia.co.jp

Innovation

3 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 115 times.

YearFilings
20212
20222
20231
20251
20261

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital457%
Private equity229%
Other / undisclosed114%
Coming soon